OOIR: Observatory of International Research

Papers

(The H4-Index of Endocrine Reviews is 46. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Update and Practical Recommendations for the Use of Medical Treatment of Cushing Syndrome	348
Antiobesity Pharmacotherapy for Patients With Genetic Obesity Due to Defects in the Leptin-Melanocortin Pathway	294
Papillary Craniopharyngioma: An Integrative and Comprehensive Review	269
Correction to: “ER Stress in Cardiometabolic Diseases: From Molecular Mechanisms to Therapeutics”	217
Bone in Parathyroid Diseases Revisited: Evidence From Epidemiological, Surgical and New Drug Outcomes	167
LGR4: A New Receptor Member in Endocrine and Metabolic Diseases	160
Coxsackievirus and Type 1 Diabetes: Diabetogenic Mechanisms and Implications for Prevention	155
DNA Damage and Repair in Thyroid Physiology and Disease	149
Medical Treatment of Acromegaly: Navigating the Present, Shaping the Future	140
Growth Hormone Action as a Target in Cancer: Significance, Mechanisms, and Possible Therapies	122
The Molecular Biology of Midgut Neuroendocrine Neoplasms	117
Effects of Maternal Vitamin D Supplementation on Childhood Health	114
A Critical Assessment of Fasting to Promote Metabolic Health and Longevity	108
The Pregnancy-Associated Plasma Protein-A (PAPP-A) Story	107
Correction to: “The Congenital and Acquired Mechanisms Implicated in the Etiology of Central Precocious Puberty”	92
Update on Biology and Genomics of Adrenocortical Carcinomas: Rationale for Emerging Therapies	89
Calcium-Sensing Receptor Regulation of Gastrointestinal Hormone Secretion	88
The Genetic Pathophysiology and Clinical Management of the TADopathy, X-Linked Acrogigantism	87
Advances in the Treatment of Gastroenteropancreatic Neuroendocrine Carcinomas: Are we Moving Forward?	87
Recent Advances in the Role of Autophagy in Endocrine-Dependent Tumors	85
Lung carcinoids (lung neuroendocrine tumors): integrated classification, molecular biology, diagnosis, and multidisciplinary management	82
The Biology and Clinical Implications of PCSK7	80
Current Challenges and Future Directions in the Assessment of Glucocorticoid Status	74
Estrogen Receptor Signaling in the Immune System	73
Biological and Therapeutic Implications of the Tumor Microenvironment in Pituitary Adenomas	66

Contemporary Biological Insights and Clinical Management of Craniopharyngioma	64
Hypoxia-Inducible Factor 2 Alpha (HIF2α) Inhibitors: Targeting Genetically Driven Tumor Hypoxia	63
Correction to: “Imaging of Pheochromocytomas and Paragangliomas”	63
Management of Growth Disorders in Puberty: GH, GnRHa, and Aromatase Inhibitors: A Clinical Review	63
Targeting Cell Senescence and Senolytics: Novel Interventions for Age-Related Endocrine Dysfunction	62
Insulin Resistance in Type 1 Diabetes: Pathophysiological, Clinical, and Therapeutic Relevance	61
Steroid receptor coactivators: from basic research to translational opportunities	59
Glycated CD59, a Novel Biomarker for Gestational Diabetes	56
Endotrophin, a Key Marker and Driver for Fibroinflammatory Disease	56
Imaging of Pheochromocytomas and Paragangliomas	55
Subtyping of Primary Aldosteronism by Adrenal Venous Sampling	55
The Cortisol Awakening Response: Regulation and Functional Significance	54
Glycerol and Glycerol-3-Phosphate: Multifaceted Metabolites in Metabolism, Cancer, and Other Diseases	53
International Consensus Guideline on Small for Gestational Age: Etiology and Management From Infancy to Early Adulthood	52
Adiponectin and Adiponectin Receptors in Atherosclerosis	51
Hippo Signaling in the Ovary: Emerging Roles in Development, Fertility, and Disease	49
Molecular and Clinical Spectrum of Primary Hyperparathyroidism	49
Brown Adipose Tissue—A Translational Perspective	48
Epigenetics and disease progression in neuroendocrine neoplasms	48
G Protein-coupled and Membrane Tyrosine Kinase Receptor Relationships Yield Therapeutic Opportunities	47
Molecular Developments in Parasellar Tumors and Potential Therapeutic Implications	47
Endocrine Controls of Skin Aging	46
The Impact of Estrogen Deficiency on Liver Metabolism: Implications for Hormone Replacement Therapy	46
Glucagon-like Peptide-1 Receptor-based Therapeutics for Metabolic Liver Disease	46